Matching slides 78,138
Current window 63,211-63,240
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

63,211-63,240 of 78,138

filter-aware
07
The slide uses a dual-axis-like conceptual chart to show price vs cost convergence, with a callout for IRA impact.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
The slide illustrates a structural biology approach to drug design, focusing on helix-receptor interactions and sequence engineering.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
14
The slide uses a combination of biological process diagrams and a bar chart to demonstrate selective inhibition.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
23
Includes photographic evidence of hair regrowth over 21 days and a bar chart showing fold reduction of NKG2D marker.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
25
Includes a blackbox warning text block as a competitive/safety barrier context.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
30
Includes a heatmap showing gene expression profiles under different cytokine conditions.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
31
The slide uses a circular process diagram to show the mechanism of action and a bar chart to show efficacy.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
36
The slide uses a Gantt-style timeline to show the duration of IP protection for various therapeutic assets.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Team1 hit
10
The chart uses a stacked bar approach to represent US and European patient counts per clinical program.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
12
The kinome tree visualization (KINOMEscan) is a standard industry tool for demonstrating kinase selectivity.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
Waterfall plot uses standard clinical trial terminology (PD, SD, PR). Comparison table highlights the study drug's performance against Dacarbazine and Binimetinib.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
18
Swimmer plot visualization of clinical trial data (Trial LXH254X2102).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
20
Swimmer plot visualization of clinical trial data.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
22
The chart displays adverse events occurring in >=10% of patients (n=15).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
37
The slide uses a stacked bar chart to show mutation incidence and a comparison table to highlight clinical trial failures in GBM despite success in other indications.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
39
The chart shows a statistically significant (***) improvement in survival for the ERAS-801 group compared to the control and other standard-of-care inhibitors.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
50
The chart displays individual patient responses categorized by dose level, with a list of specific notable responses on the right.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
51
The chart displays patient-level data including cancer type, mutation, weekly dose, and response status (Partial Response, Stable Disease, Progressive Disease).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
53
The slide compares various dosing schedules (QW, BID-QW, BIW) against IC90 and IC50 thresholds.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
06
Includes seller census data and growth metrics.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · Solution1 hit
18
The chart shows negative growth rates that are trending toward zero, which the company frames as 'the right direction'.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
20
The chart shows a clear upward trend in GMS growth, moving from negative territory in early 2023 to positive growth by May and June.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
21
The chart uses a waterfall-like visual to show sequential growth/decline rates, though it is technically a bar chart of Q/Q changes.Etsy | Investor Presentation Deck | 34 slides · Etsy
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
24
The chart uses a waterfall-like layout to show negative growth percentages, with the most recent quarter (Q2 23) showing the smallest decline.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations Loop · So What Cascade1 hit
25
The chart visualizes a recovery trend in GMS growth.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations Loop · So What Cascade1 hit
26
The donut chart shows a near-even split between U.S. and non-U.S. GMS.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations 1 hit
27
The slide uses a split-screen layout: left side shows bar charts for category performance, right side highlights specific 'horizontal' category growth with illustrative photos.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations 1 hit
28
The chart shows a steady increase in active buyers over the 4-year period, with a slight dip in 2022 before reaching a new peak in 2023.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations 1 hit
29
The slide uses a waterfall-style bar chart to show sequential growth rates, with a supporting metric comparing current performance to pre-pandemic levels.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations 1 hit
32
Includes a footnote regarding cash and investment definitions.Etsy | Results Presentation Deck | 42 slides · Etsy
Conference presentation Investor relations 1 hit